A Leishmania major nucleobase transporter responsible for allopurinol uptake is a functional homolog of the Trypanosoma brucei H2 transporter

Molecular Pharmacology

Volumn 63, Issue 4, 2003, Pages 814-820

  Al Salabi, Mohammed I ^a   Wallace, Lynsey J M ^a   De Koning, Harry P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALLOPURINOL; ANTILEISHMANIAL AGENT; ANTIPARASITIC AGENT; GUANINE; HYPOXANTHINE; NUCLEIC ACID BASE; NUCLEOBASE TRANSPORTER; PURINE; PURINE DERIVATIVE; UNCLASSIFIED DRUG; XANTHINE;

ARTICLE; AUXOTROPHY; BINDING SITE; HYDROGEN BOND; LEISHMANIA MAJOR; PARASITE; PRIORITY JOURNAL; PROTOZOON; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA BRUCEI;

ADENINE; ALLOPURINOL; ANIMALS; BIOLOGICAL TRANSPORT; HYPOXANTHINE; LEISHMANIA MAJOR; NUCLEOBASE TRANSPORT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRITIUM; TRYPANOSOMA BRUCEI BRUCEI;

EID: 0037379670     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.4.814     Document Type: Article

References (35)

1. Abrishami M, Soheilian M, Farahi A, and Dowlati Y (2002) Successful treatment of ocular leishmaniasis. Eur J Dermatol 12:88-89.
2. Allen TE, Hwang H-Y, Jardim A, Olafson R, and Ullman B (1995) Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase from Leishmania donovani. Mol Biochem Parasitol 73:133-143.
3. Barrett MP and Fairlamb AH (1999) The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol Today 15:136-140.
4. Baum KF and Berens RL (1994) Successful treatment of cutaneous leishmaniasis with allopurinol after failure of treatment with ketoconazole. Clin Infect Dis 18:813-815.
5. Becker I, Volkow P, Velasco-Castrejon O, Salaiza-Suazo N, Berzunza-Cruz M, Sotero-Delgado Dominguez J, Morales-Vargas A, Ruiz-Remigio A, and Perez-Montfort R (1999) The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasis. Parasitol Res 85:165-170.
6. Berens RL, Krug EC, and Marr JJ (1995) Purine and pyrimidine metabolism, in Biochemistry and Molecular Biology ofParasites (Marr JJ and Müller M eds) pp 89-117, Harcourt Brace & Company, London, UK.
7. Carter NS, Drew ME, Sanchez M, Vasudevan G, Landfear SM, and Ullman B (2000) Cloning of a novel inosine-guanosine transporter gene from Leishmania donovani by functional rescue of a transporter-deficient mutant. J Biol Chem 275:20935-20941.
8. Carter NS and Fairlamb AH (1993) Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature (Lond) 361:173-176.
9. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
10. Croft SL (2001) Monitoring drug resistance in leishmaniasis. Trop Med Int Health 6:899-905.
11. Cui L, Rajasekariah GR, and Martin SK (2001) A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite. Gene 280:153-162.
12. Das VN, Ranjan A, Sinha AN, Verma N, Lal CS, Gupta AK, Siddiqui NA, and Kar SK (2001) A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis. J Assoc Physicians India 49:609-613.
13. De Koning HP and Diallinas G (2000) Nucleobase transporters. Mol Membr Biol 75:75-94.
14. De Koning HP and Jarvis SM (1997a) Hypoxanthine uptake through a purine-selective nucleobase transporter in Trypanosoma brucei brucei procyclics is driven by protonmotive force. Eur J Biochem 247:1102-1110.
15. De Koning HP and Jarvis SM (1997b) Purine nucleobase transport in bloodstream forms of Trypanosoma brucei brucei is mediated by two novel transporters. Mol Biochem Parasitol 89:245-258.
16. De Koning HP and Jarvis SM (1999) Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanosomal drugs. Mol Pharmacol 56:1162-1170.
17. De Koning HP (2001) Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters. Implications for crossresistance with arsenicals. Mol Pharmacol 59:586-592.
18. Ghosh M and Mukherjee T (2000) Stage-specific development of a novel adenosine transporter in Leishmania donovani amastigotes. Mol Biochem Parasitol 108:93-99.
19. Hansen BD, Perez-Arbelo J, Walkony JF, and Hendricks LD (1982) The specificity of purine base and nucleoside uptake in promastigotes of Leishmania braziliensis panamensis. Parasitology 85:271-282.
20. Hassan HF and Coombs GH (1988) Purine and pyrimidine metabolism in parasitic protozoa. FEMS Microbiol Rev 54:47-84.
21. Hyde RJ, Cass CE, Young JD, and Baldwin SA (2001) The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18:53-63.
22. Jardim A, Bergeson SE, Shih S, Carter N, Lucas RW, Merlin G, Myler PJ, Stuart K, and Ullman B (1999) Xanthine phosphoribosyltransferase from Leishmania donovani; molecular cloning, biochemical characterisation and genetic analysis. J Biol Chem 274:34403-34410.
23. Llorente S, Gimeno L, Navarro MJ, Moreno S, and Rodriguez-Girones M (2000) Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials. Transplantation 70:800-801.
24. Martinez S and Marr JJ (1992) Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 326:741-744.
25. Marr JJ and Berens RL (1983) Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae. Mol Biochem Parasitol 7:339-356.
26. Momeni AZ, Reiszadae MR, and Aminjavaheri M (2002) Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimomate. Int J Dermatol 41:441-443.
27. Nelson JD, Bugge CJL, Elion GB, Berens RL, and Marr JJ (1979) Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani: allopurinol, oxypurinol and 4-aminopyrazolo(3,4-d)pyrimidine. J Biol Chem 254:3959-3964.
28. Phillips CL, Ullman B, Brennan RG, and Hill CP (1999) Crystal structures of adenine phosphoribosyltransferase from Leishmania donovani. EMBO (Eur Mol Biol Organ) J 18:3533-3545.
29. Shi W, Schramm VL, and Almo SC (1999) Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors and the 2.5-a crystal structure. J Biol Chem 274:21114-21120.
30. Sinha KM, Ghosh M, Das I, and Datta AK (1999) Molecular cloning and expression of adenosine kinase from Leishmania donovani: identification of unconventional P-loop motif. Biochem J 339:667-673.
31. Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6:849-854.
32. Thiemann OH, Alfonzo JD, and Simpson L (1998) Cloning and characterisation of Leishmania tarentolae adenine phosphoribosyltransferase. Mol Biochem Parasitol 95:141-146.
33. Vasudevan G, Carter NS, Drew ME, Beverley SM, Sanchez MA, Seyfang A, Ullman B, and Landfear SM (1998) Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant. Proc Natl Acad Sci USA 95:9873-9878.
34. Vasudevan G, Ullman B, and Landfear SM (2001) Point mutations in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity. Proc Natl Acad Sci USA 98:6092-6097.
35. Wallace LJM, Candlish D, and De Koning HP (2002) Different substrate recognition motifs of human and trypanosome nucleobase transporters: selective uptake of purine antimetabolites. J Biol Chem 277:26149-26156.